Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective

References

• Lyman GH, Berndt ER, Kallich JD, et al. The economic burden of anemia in cancer patients receiving chemotherapy. Value Health 2005;8:149-56
   PubMed Web of Science ®Google Scholar
• Nissenson AR, Wade S, Goodnough T, et al. Economic burden of anemia in an insured population. J Manag Care Pharm 2005;11:565-74
   PubMedGoogle Scholar
• Ershler WB, Chen K, Reyes EB, et al. Economic burden of patients with anemia in selected diseases. Value Health 2005;8:629-38
   PubMed Web of Science ®Google Scholar
• Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95
   PubMed Web of Science ®Google Scholar
• Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616-34
   PubMed Web of Science ®Google Scholar
• Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol 1998;25:2-6
   PubMed Web of Science ®Google Scholar
• Littlewood TJ. Erythropoietin for the treatment of anemia associated with hematological malignancy. Hematol Oncol 2001;19:19-30
   PubMed Web of Science ®Google Scholar
• Spielmann M, Luporsi E, Ray-Coquard I, et al. Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study. Eur J Cancer in press
   Web of Science ®Google Scholar
• Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81:2-10
   PubMed Web of Science ®Google Scholar
• Feagan BG, Wong CJ, Lau CY, et al. Transfusion practice in elective orthopaedic surgery. Transfus Med 2001;11:87-95
   PubMed Web of Science ®Google Scholar
• Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43:459-69
   PubMed Web of Science ®Google Scholar
• Bong MR, Patel V, Chang E, et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004;19:281-7
   PubMed Web of Science ®Google Scholar
• Seidenfeld J, Piper M, Flamm C, et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst 2001;93:1204-14
   PubMed Web of Science ®Google Scholar
• Shander A, Spence RK, Auerbach M. Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents? Transfusion 2010;50:719-32
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009;69:739-56
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 2004;40:2201-16
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258-70
   PubMed Web of Science ®Google Scholar
• Auerbach M, Ballard H, Trout JR, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 2004;22:1301-7
   PubMed Web of Science ®Google Scholar
• Pedrazzoli P, Farris A, Del Prete S, et al. Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. J Clin Oncol 2008;26:1619-25
   PubMed Web of Science ®Google Scholar
• Cuenca J, Garcia-Erce JA, Martinez AA, et al. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 2005;125:342-7
   PubMed Web of Science ®Google Scholar
• Cuenca J, Garcia-Erce JA, Munoz M, et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004;44:1447-52
   PubMed Web of Science ®Google Scholar
• Bastit L, Vandebroek A, Altintas S, et al. Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. J Clin Oncol 2008;26:1611-8
   PubMed Web of Science ®Google Scholar
• Henry DH, Dahl NV, Auerbach M, et al. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. The Oncologist 2007;12:231-42
   PubMed Web of Science ®Google Scholar
• Hedenus M, Birgegard G, Nasman P, et al. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study. Leukemia 2007;21:627-32
   PubMed Web of Science ®Google Scholar
• Institut National de Veille Sanitaire. Evolution de l’incidence et de la mortalité par cancer en France de 1980 à 2005. Fiche: sein. 30 Janvier 2008. Estimations à partir des données des registres du réseau FRANCIM et du CepiDC. http://www.invs.sante.fr/surveillance/cancers/mortalite_1980_2005/donnees_localisation/sein/sein.pdf. Accessed November 21, 2011
   Google Scholar
• Haute Autorité de Santé. Commission de la transparence. Taxotère. Avis du 15 Février 2006. http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032531.pdf. Accessed November 21, 2011
   Google Scholar
• Institut de Veille Sanitaire. Bulletin Epidémiologique Hebdomadaire. Numéro thématique - Dépistage organisé du cancer colorectal en France. n°2–3. 13 January 2009, Paris
   Google Scholar
• Bouvier AM, Remontet L, Jougla E, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol 2004;28:877-81
   PubMed Web of Science ®Google Scholar
• Schneider M. Fréquence de l'anémie chez les patients français atteints de tumeurs solides ou d'hémopathies malignes: résultats de l’ “European Cancer Anaemia Survey (ECAS)”. Oncologie 2005;7:397-702
   Google Scholar
• Rodgers et al. Cancer- and Chemotherapy-induced anemia. Clinical Practice Guidelines in Oncology. Version 2. 2012. National Comprehensive Cancer Network (NCCN), United States. http://www.nccn.org/professionals/physician_gls/pdf/anemia.pdf. Accessed November 21, 2011
   Google Scholar
• Auerbach M. New intravenous iron replacement therapies. Clin Adv Hematol Oncol 2010;8:688-9
   PubMedGoogle Scholar
• Pigeon M, Courtois J, Rigollot N and Samson S. Les médicaments les plus prescrits en France. Consensus Cardio n° 47, March 2009. http://www.consensus-online.fr/spip.php?article323. Accessed November 23, 2011
   Google Scholar
• Ludwig H, Aapro M, Bokemeyer C, et al. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. Eur J Cancer 2009;45:1603-15
   PubMed Web of Science ®Google Scholar
• Steiner S, Brock E, Schneider H. Budget impact of parenteral iron treatment of iron deficiency anaemia in Switzerland. Abstract no. PHM2. Value Health 2007;10:A280
   Web of Science ®Google Scholar
• Auerbach M. Should intravenous iron be the standard of care in oncology? J Clin Oncol 2008;26:1579-81
   PubMed Web of Science ®Google Scholar
• Hedenus M, Nasman P, Liwing J. Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy. J Clin Pharm Ther 2008;33:365-74
   PubMed Web of Science ®Google Scholar